Literature DB >> 4601669

Phase I clinical trial of a single-dose and two weekly schedules of ICRF-159 (NSC-129943).

P J Creaven, M H Cohen, H H Hansen, O S Selawry, S G Taylor.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4601669

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  3 in total

1.  Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors.

Authors:  C L Vogel; E Gorowski; E Davila; M Eisenberger; J Kosinski; R P Agarwal; N Savaraj
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

2.  The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo.

Authors:  R H Wheeler; D J Clauw; R B Natale; R W Ruddon
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

3.  Combination therapy of a mouse sarcoma using razoxane and electron irradiation.

Authors:  M B Grimshaw; R W Davies; W S Hall
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.